Hostname: page-component-78c5997874-j824f Total loading time: 0 Render date: 2024-11-17T16:12:21.478Z Has data issue: false hasContentIssue false
  • English
  • Français

Screening for MRSA: A Flawed Hospital Infection Control Intervention

Published online by Cambridge University Press:  02 January 2015

Richard P. Wenzel ,
Gonzalo Bearman  and
Michael B. Edmond
Richard P. Wenzel*
Affiliation:
Department of Internal Medicine, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, Virginia
Gonzalo Bearman
Affiliation:
Department of Internal Medicine, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, Virginia
Michael B. Edmond
Affiliation:
Department of Internal Medicine, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, Virginia
*
1001 East Broad Street, PO Box 980663, Richmond, VA 23298
Get access Rights & Permissions [Opens in a new window]

Abstract

Focusing hospital resources on a single antibiotic-resistant pathogen as a sole approach to infection control is inherently flawed. We applied attributable mortality principles to a basic model of bloodstream infections to outline the argument. Screening for methicillin-resistant Staphylococcus aureus alone made sense in the 1980s, but the ongoing emergence of vancomycin-resistant enterococci and antibiotic-resistant strains of gram-negative rods and Candida species, as well as the recognition of the value of team-based infection control programs, support a population-based approach.

Type
Original Article
Information
Infection Control & Hospital Epidemiology , Volume 29 , Issue 11 , November 2008 , pp. 1012 - 1018
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Lowy, FD. Antimicrobial resistance: the example of Staphylococcus aureus. J Clin Invest 2003;111:1265–1273.CrossRefGoogle ScholarPubMed
2.Klevens, RM, Morrison, MA, Nadle, J, et al.Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007;298:1763–1771.CrossRefGoogle ScholarPubMed
3.Wenzel, RP, Bearman, G, Edmond, MB. Community-acquired methicillin-resistant Staphylococcus aureus (MRSA): new issues for infection control. Int J Antimicrob Agents 2007;30:210–212.CrossRefGoogle ScholarPubMed
4.Huang, SS, Yokoe, DS, Hinrichsen, VL, et al.Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 2006;43:971–978.CrossRefGoogle ScholarPubMed
5.Robicsek, A, Beaumont, MS, Paule, SM, et al.Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Ann Intern Med 2008;148:409–418.CrossRefGoogle ScholarPubMed
6.Wertheim, HF, Vos, MC, Boelens, HA, et al.Low prevalence of methicillin-resistant Staphylococcus aureus (MRSA) at hospital admission in the Netherlands: the value of search and destroy and restrictive antibiotic use. J Hosp Infect 2004;56:321–325.CrossRefGoogle ScholarPubMed
7.Herr, CE, Heckrodt, TH, Hofmann, FA, Schnettler, R, Eikmann, TF. Additional costs for preventing the spread of methicillin-resistant Staphylococcus aureus and a strategy for reducing these costs on a surgical ward. Infect Control Hosp Epidemiol 2003;24:673–678.CrossRefGoogle Scholar
8.Saint, S, Higgins, LA, Nallamothu, BK, Chenoweth, C. Do physicians examine patients in contact isolation less frequently? A brief report. Am J Infect Control 2003;31:354–356.CrossRefGoogle ScholarPubMed
9.Kirkland, KB, Weinstein, JM. Adverse effects of contact isolation. Lancet 1999;354:1177–1178.CrossRefGoogle ScholarPubMed
10.Evans, HL, Shaffer, MM, Hughes, MG, et al.Contact isolation in surgical patients: a barrier to care? Surgery 2003;134:180–188.CrossRefGoogle ScholarPubMed
11.Catalano, G, Houston, SH, Catalano, MC, et al.Anxiety and depression in hospitalized patients in resistant organism isolation. South Med J 2003;96:141–145.CrossRefGoogle ScholarPubMed
12.Tarzi, S, Kennedy, P, Stone, S, Evans, M. Methicillin-resistant Staphylococcus aureus: psychological impact of hospitalization and isolation in an older adult population. J Hosp Infect 2001;49:250–254.CrossRefGoogle Scholar
13.Stelfox, HT, Bates, DW, Redelmeier, DA. Safety of patients isolated for infection control. JAMA 2003;290:1899–1905.CrossRefGoogle ScholarPubMed
14.Wisplinghoff, H, Bischoff, T, Tallent, SM, Seifert, H, Wenzel, RP, Edmond, MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004;39:309–317.CrossRefGoogle Scholar
15.Turner, PJ. Meropenem and imipenem activity against Pseudomonas aeruginosa isolates from the MYSTIC Program. Diagn Microbiol Infect Dis 2006;56:341–344.CrossRefGoogle ScholarPubMed
16.Dijkshoorn, L, Nemec, A, Seifert, H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 2007;5:939–951.CrossRefGoogle ScholarPubMed
17.Wenzel, RP, Edmond, MB. Team-based prevention of catheter-related infections. N Engl J Med 2006;355:2781–2783.CrossRefGoogle ScholarPubMed
18.Pronovost, P, Needham, D, Berenholtz, S, et al.An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006;355:2725–2732.CrossRefGoogle ScholarPubMed
19.Wenzel, RP, Edmond, MB. The impact of hospital-acquired bloodstream infections. Emerg Infect Dis 2001;7:174–177.CrossRefGoogle ScholarPubMed
20.Klevens, RM, Edwards, JR, Richards, CL Jr, et al.Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep 2007;122:160–166.CrossRefGoogle ScholarPubMed
21.Wenzel, RP. The mortality of hospital acquired bloodstream infections: need for a new vital statistic. Trans Am Clin Climatol Assoc 1987;98:43–48.Google ScholarPubMed
22.Wenzel, RP. Perspective: attributable mortality-the promise of better antimicrobial therapy. J Infect Dis 1998;178:917–919.CrossRefGoogle ScholarPubMed
23.Digiovine, B, Chenoweth, C, Watts, C, Higgins, M. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med 1999;160:976–981.CrossRefGoogle ScholarPubMed
24.Pittet, D, Tarara, D, Wenzel, RP. Nosocomial bloodstream infections in critically ill patients. JAMA 1994;271:1598–1601.CrossRefGoogle ScholarPubMed
25.NNIS System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004;32:470–485.CrossRefGoogle Scholar
26.NNIS System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January through June 2003, issued August 2003. Am J Infect Control 2003;31:481–498.CrossRefGoogle Scholar
27.Obritsch, MD, Fish, DN, MacLaren, R, Jung, R. National surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolates obtained from intensive care unit patients from 1993 to 2002. Antimicrob Agents Chemother 2004;48:4606–4610.CrossRefGoogle ScholarPubMed
28.Pfaller, MA, Diekema, DJ, Gibbs, DL, et al.Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing. J Clin Microbiol 2007;45:1735–1745.CrossRefGoogle ScholarPubMed
29.Turner, PJ. Meropenem and imipenem activity against Pseudomonas aeruginosa isolates from the MYSTIC Program. Diagn Microbiol Infect Dis 2006;56:341–344.CrossRefGoogle ScholarPubMed
30.NNIS. National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992-April 2000, issued June 2000. Am J Infect Control 2000;28:429–448.CrossRefGoogle Scholar
31.Dijkshoorn, L, Nemec, A, Seifert, H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 2007;5:939–951.CrossRefGoogle ScholarPubMed
32.Klevens, RM, Edwards, JR, Tenover, FC, et al.Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in U.S. hospitals, 1992-2003. Clin Infect Dis 2006;42:389–391.Google Scholar
33.Edmond, MB, Wallace, SE, McClish, DK, et al.Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 1999;29:239–241.Google Scholar
34.Panlilio, AL, Culver, DH, Gaynes, RP, et al.Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991. Infect Control Hosp Epidemiol 1992;13:582–586.Google ScholarPubMed
35.Peacock, JE, Marsik, FJ, Wenzel, RP. Methicillin-resistant Staphylococcus aureus: introduction and spread within a hospital. Ann Intern Med 1980;93:526–532.Google Scholar
36.Thompson, RL, Cabezudo, I, Wenzel, RP. Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. Ann Intern Med 1982;97:309–317.CrossRefGoogle ScholarPubMed
37.Reagan, DR, Doebbeling, BN, Pfaller, MA, et al.Elimination of coincident Staphylococcus aureus nasal and hand carriage with intranasal application of mupirocin calcium ointment. Ann Intern Med 1991;114:101–106.CrossRefGoogle ScholarPubMed
38.Doebbeling, BN, Reagan, DR, Pfaller, MA, Houston, AK, Hollins, RJ, Wenzel, RP. Long-term efficacy of intranasal mupirocin ointment: a prospective cohort study of Staphylococcus aureus carriage. Arch Intern Med 1994;154:1505–1508.CrossRefGoogle ScholarPubMed
39.Redhead, RJ, Lamb, YJ, Rowsell, RB. The efficacy of calcium mupirocin in the eradication of nasal Staphylococcus aureus carriage. Br J Clin Pratt 1991;45:252–254.Google ScholarPubMed
40.Vandenbroucke-Grauls, CM, Frenay, HM, van Klingeren, B, Savelkoul, TF, Verhoef, J. Control of epidemic methicillin-resistant Staphylococcus aureus in a Dutch university hospital. Eur J Clin Microbiol Infect Dis 1991;10:6–11.CrossRefGoogle Scholar
41.Hartstein, AI, Denny, MA, Morthland, VH, LeMonte, AM, Pfaller, MA. Control of methicillin-resistant Staphylococcus aureus in a hospital and an intensive care unit. Infect Control Hosp Epidemiol 1995;16:405–411.Google Scholar
42. Swabs in hand, hospital cuts deadly infections. New York Times. January 13, 2008.Google Scholar
43.Harbarth, S, Fankhauser, C, Schrenzel, J, et al.Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA 2008;299:1149–1157.Google Scholar
44.Jayarantnam, D, Whitty, CJ, Phillips, K, et al.Impact of rapid screening tests on acquisition of methicillin-resistant Staphylococcus aureus: cluster randomized crossover trial. BMJ 2008;336:927–930.Google Scholar
45.Diekema, DJ, Edmond, MB. Look before you leap: active surveillance for multidrug-resistant organisms. Clin Infect Dis 2007;44:1101–1107.Google ScholarPubMed
46.Edmond, MB, Ober, JF, Bearman, G. Active surveillance cultures are not required to control MRSA infections in the critical care setting. Am J Infect Control 2008;36:461–463.CrossRefGoogle Scholar
47.Musser, JM, Kapur, V. Clonal analysis of methicillin-resistant Staphylococcus aureus strains from intercontinental sources: association of the mec gene with divergent phylogenetic lineages implies dissemination by horizontal transfer and recombination. J Clin Microbiol 1992;30:2058–2063.CrossRefGoogle ScholarPubMed
48.NNIS. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004;32:470–485.CrossRefGoogle Scholar
49.McGowan, JE Jr. Resistance in nonfermenting gram-negative bacteria: multidrug resistance to the maximum. Am J Infect Control 2006;34 (Suppl 1):S29–37; discussion S64-73.CrossRefGoogle ScholarPubMed
50.Edmond, MB, Ober, JF, Dawson, JD, Weinbaum, DL, Wenzel, RP. Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality. Clin Infect Dis 1996;23:1234–1240.CrossRefGoogle ScholarPubMed
51.Wey, SB, Mori, M, Pfaller, MA, Woolson, RF, Wenzel, RRHospital-acquired candidemia: the attributable mortality and excess length of stay. Arch Intern Med 1988;148:2642–2647.CrossRefGoogle ScholarPubMed
52.von Eiff, C; Becker, K; Machka, K; Stammer, H; Peters, G. Nasal carriage as a source of Staphylococcus aureus bacteremia. N Engl J Med 2001;344:11–16.CrossRefGoogle ScholarPubMed
53.Widmer, A, Mertz, D, Frei, R. Necessity of screening both the nose and the throat to detect methicillin-resistant Staphylococcus aureus colonization in patients upon admission to an intensive care unit. J Clin Microbiol 2008;46:835.CrossRefGoogle Scholar
54.Marshall, C, Spelman, D. Re: is throat screening necessary to detect methicillin-resistant Staphylococcus aureus colonization in patients upon admission to an intensive care unit? J Clin Microbiol 2007;45:38–55.CrossRefGoogle Scholar
55.Zafar, U, Johnson, LB, Hanna, M, et al.Prevalence of nasal colonization among patients with community-associated methicillin-resistant Staphylococcus aureus infection and their household contacts. Infect Control Hosp Epidemiol 2007;28:966–969.CrossRefGoogle ScholarPubMed
56.Cook, HA, Furoya, EY, Larson, E, Vasquez, G, Lowy, FD. Heterosexual transmission of community-acquired methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2007;44:410–413.CrossRefGoogle Scholar
57.Muto, CA, Jernigan, JA, Ostrowsky, BE, et al.SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 2003;24:362–386.Google Scholar
58.Davis, KA, Stewart, JJ, Crouch, HK, et al.Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection. Clin Infect Dis 2004;39:776–782.CrossRefGoogle ScholarPubMed
59.Datta, R, Huang, SS. Risk of infection and death due to methicillin-resistant Staphylococcus aureus in long term carriers. Clin Infect Dis 2008;47:176–181.CrossRefGoogle ScholarPubMed
60.van Rijen, MM, Bonten, M, Wenzel, RP, Kluytmans, JA. Intranasal mupirocin for reduction of Staphylococcus aureus infections in surgical patients with nasal carriage: a systematic review. J Antimicrob Chemother 2008;61:254–261.CrossRefGoogle ScholarPubMed
61.Wenzel, RP. The antibiotic pipeline-challenges, costs, and values. N Engl J Med 2004;351:523–526.CrossRefGoogle ScholarPubMed
62.Doebbeling, BN, Stanley, GL, Sheetz, CT, et al.Comparative efficacy of alternative hand-washing agents in reducing nosocomial infections in intensive care units. N Engl J Med 1992;327:88–93.CrossRefGoogle ScholarPubMed
63.Trick, WE, Vernon, MO, Welbel, SF, et al.Multicenter intervention program to increase adherence to hand hygiene recommendations and glove use and to reduce the incidence of antimicrobial resistance. Infect Control Hosp Epidemiol 2007;28:42–49.Google Scholar
64.Edmond, MB, Bearman, GM. Mandatory public reporting in the USA: an example to follow? J Hosp Infect 2007;65(Suppl 2): 182–188.CrossRefGoogle ScholarPubMed